Zyrtec-D - Risks of posterior reversible encephalopathy syndrome and reversible cerebral vasoconstriction syndrome associated with the use of pseudoephedrine

Posterior Reversible Encephalopathy Syndrome and Reversible Cerebral Vasoconstriction Syndrome as Syndromes of Cerebrovascular Dysregulation

Posterior reversible encephalopathy syndrome: A review with emphasis on neuroimaging characteristics - ScienceDirect

Drug Office - Pharmaceutical Trade Homepage

Drug Office - Pharmaceutical Trade Homepage

Evaluation and treatment approaches for neurological post-acute sequelae of COVID-19: A consensus statement and scoping review from the global COVID-19 neuro research coalition - ScienceDirect

PDF) Pseudoephedrine—Benefits and Risks

Sci. Pharm., Free Full-Text

藥物辦公室– 藥劑業界主頁

Drug Office - Pharmaceutical Trade Homepage

Pheochromocytoma Anesthesia

Drugs Associated With Ischemic Stroke

药物办公室– 药剂业界主页